Reborna Biosciences, Inc.
PrivateLast Round
VC Round
Jun 25, 2025
Total Funding Raised
$7.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Reborna Biosciences, Inc. operates in Healthcare & Life Sciences and is based in Fujisawa. Its latest recorded funding round was a VC Round in June 2025.
Reborna Biosciences, Inc. is a biotechnology company that develops RNA-targeting small molecule drugs for the treatment of rare genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reborna Biosciences, Inc. Comparables
Compare Reborna Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| xFOREST Therapeutics Co., Ltd. | 87% | |
| Serna Bio | 85% | |
| Ribometrix | 83% |
For institutional investors. Book with your work email.
Reborna Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 25, 2025 | ||||
| Series D | May 25, 2023 | ||||
| Seed | Jun 25, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Reborna Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| THE GOGIN CAPITAL Co., Ltd. | VC Round |
| Angel Bridge | Series D, VC Round |
| Nissay Capital | VC Round, Series D |
| ICMG Group | VC Round |
| Mitsubishi UFJ Capital | Seed |
| Yokohama Capital Co., Ltd. | VC Round |
| UntroD Capital Japan Inc. | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 67% MoM, reaching 1.8K.
- Jun 1, 2025
Monthly visitors grew 164% MoM, reaching 867.
For institutional investors. Book with your work email.
Reborna Biosciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reborna Biosciences, Inc.'s valuation, stock price, and market status.
Is Reborna Biosciences, Inc. a public or private company?
Reborna Biosciences, Inc. is a private company.
What is the current stock price of Reborna Biosciences, Inc.?
Reborna Biosciences, Inc. is a private company, so its shares have no public market price. Caplight tracks Reborna Biosciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reborna Biosciences, Inc. worth (valuation)?
Valuation information for Reborna Biosciences, Inc. is not publicly available.
Can I buy Reborna Biosciences, Inc. stock?
Reborna Biosciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reborna Biosciences, Inc.'s last funding round?
Reborna Biosciences, Inc.'s most recent funding round was VC Round on June 25, 2025.
Who are the main investors in Reborna Biosciences, Inc.?
Key investors in Reborna Biosciences, Inc. include Nissay Capital.
Will Reborna Biosciences, Inc. IPO soon?
No public IPO plans have been announced for Reborna Biosciences, Inc..
How can I track Reborna Biosciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Reborna Biosciences, Inc.'s shares on secondary markets.